scholarly journals A sociotechnical approach to vaccine manufacturer selection as part of a global immunization strategy against epidemics and pandemics

2022 ◽  
Author(s):  
Fernando A. F. Ferreira ◽  
Devika Kannan ◽  
Ieva Meidutė-Kavaliauskienė ◽  
Inês M. T. Vale
Keyword(s):  
Immunization Strategy ◽  
Vaccine Manufacturer

IMMUNIZATION STRATEGY IN A FUZZY ENVIRONMENT

2007 ◽  
Vol 12 (02) ◽  
Author(s):  
A. Terceño Gómez ◽  
A. Fernández Bariviera ◽  
J. M. Brotons Martí­nez
Keyword(s):  
Immunization Strategy ◽  
Fuzzy Environment

Immunization strategy by cutting edges

2010 ◽  
Vol 30 (7) ◽  
pp. 1775-1777
Author(s):  
Peng JI ◽  
Hong-wei GE
Keyword(s):  
Immunization Strategy

scholarly journals An Overview of Equine Influenza in South America

Viruses ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 888
Author(s):  
Cecilia Olguin-Perglione ◽  
María Edith Barrandeguy
Keyword(s):  
South America ◽  
Disease Surveillance ◽  
Economic Losses ◽  
South American ◽  
Respiratory Pathogens ◽  
Equine Influenza Virus ◽  
Equine Influenza ◽  
Vaccine Manufacturer ◽  
Gene Level ◽  
Control Procedures

Equine influenza virus (EIV) is one of the most important respiratory pathogens of horses as outbreaks of the disease lead to significant economic losses worldwide. In this review, we summarize the information available on equine influenza (EI) in South America. In the region, the major events of EI occurred almost in the same period in the different countries, and the EIV isolated showed high genetic identity at the hemagglutinin gene level. It is highly likely that the continuous movement of horses, some of them subclinically infected, among South American countries, facilitated the spread of the virus. Although EI vaccination is mandatory for mobile or congregates equine populations in the region, EI outbreaks continuously threaten the equine industry. Vaccine breakdown could be related to the fact that many of the commercial vaccines available in the region contain out-of-date EIV strains, and some of them even lack reliable information about immunogenicity and efficacy. This review highlights the importance of disease surveillance and reinforces the need to harmonize quarantine and biosecurity protocols, and encourage vaccine manufacturer companies to carry out quality control procedures and update the EIV strains in their products.

scholarly journals Antibody level of New Zealand children immunized with the triple vaccine DTP (diphtheria-tetanus-pertussis)

1988 ◽  
Vol 101 (2) ◽  
pp. 405-410 ◽  
Author(s):  
R. C. H Lau
Keyword(s):  
New Zealand ◽  
Immunosorbent Assay ◽  
Antibody Level ◽  
Herd Immunity ◽  
Enzyme Linked Immunosorbent Assay ◽  
Igg Antibody ◽  
Immunization Strategy ◽  
The Mean ◽  
Antibody Levels

SUMMARYEnzyme-linked immunosorbent assay (ELISA) tests were used to measure IgG antibody levels in 2638 New Zealand children who had been immunized with the triple vaccine DTP. The percentage of children immune to diphtheria decreased with age. The percentage of children immune to tetanus varied from 67.1 to 55.0%. The percentage of children with measurable antibody to pertussis increased with age. The mean percentages of children with measurable antibody or immunity to one or more DTP components were 34.2% (with 3 components), 34.4% (2 components), and 78.1% (1 component). It appears the immunization strategy for diphtheria and tetanus is satisfactory for herd immunity in New Zealand children. However, the current pertussis strategy may not be providing adequate immunity to 5-year-olds in this country.

Heterogeneity-Oriented Immunization Strategy on Multiplex Networks

2019 ◽  
pp. 678-690
Author(s):  
Yingchu Xin ◽  
Chunyu Wang ◽  
Yali Cui ◽  
Chao Gao ◽  
Xianghua Li
Keyword(s):  
Immunization Strategy ◽  
Multiplex Networks
Sign in / Sign up

Export Citation Format

Share Document